Literature DB >> 1641587

Serodiagnosis of Helicobacter pylori-associated gastritis with a monoclonal antibody competitive enzyme-linked immunosorbent assay.

R Negrini1, I Zanella, A Savio, C Poiesi, R Verardi, S Ghielmi, A Albertini, O Sangaletti, M Lazzaroni, G Bianchi Porro.   

Abstract

Forty-nine monoclonal antibodies against Helicobacter pylori were screened to investigate their capacity to be used in enzyme-linked immunosorbent assay (ELISA) competitive systems for the serodiagnosis of Helicobacter pylori infection. On the basis of the inhibition pattern showed by the sera of five infected patients, the antibodies were subdivided into five groups. The immunoblotting analysis showed that the antibodies recognized a total of nine different antigenic determinants. In a study of the reaction of the antibodies with 12 isolates of H. pylori a total of 9 antigenic profiles were identified. Two monoclonal antibodies, HpN44 and HpN45, which recognized a 64-kD protein, were inhibited by all 5 positive sera. Antibody HpN45 was labeled with horseradish peroxidase, and the competitive ELISA was compared with an ordinary indirect ELISA in a study of 102 patients undergoing gastroscopy. Seventy-three patients proved to be infected by H. pylori according to urease or histologic tests. The sensitivity and specificity were 90.4% and 89.6%, respectively, for the indirect ELISA and 100% and 89.6% for the HpN45 competitive assay. The three patients who were 'false seropositive' with both serologic tests had atrophic gastritis. The high diagnostic performance and simplicity of the HpN45 monoclonal competitive ELISA make it suitable for routine serodiagnosis of H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641587     DOI: 10.3109/00365529209000125

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis.

Authors:  Bruno Annibale; Edith Lahner; Riccardo Negrini; Flavia Baccini; Cesare Bordi; Bruno Monarca; Gianfranco Delle Fave
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

2.  Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide.

Authors:  I M Simoons-Smit; B J Appelmelk; T Verboom; R Negrini; J L Penner; G O Aspinall; A P Moran; S F Fei; B S Shi; W Rudnica; A Savio; J de Graaff
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

3.  Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity.

Authors:  B J Appelmelk; I Simoons-Smit; R Negrini; A P Moran; G O Aspinall; J G Forte; T De Vries; H Quan; T Verboom; J J Maaskant; P Ghiara; E J Kuipers; E Bloemena; T M Tadema; R R Townsend; K Tyagarajan; J M Crothers; M A Monteiro; A Savio; J De Graaff
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Comparison of different criteria for interpretation of immunoglobulin G immunoblotting results for diagnosis of Helicobacter pylori infection.

Authors:  Philipp M Lepper; Angelika Möricke; Konstanze Vogt; Günter Bode; Matthias Trautmann
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

5.  Augmentation of Autoantibodies by Helicobacter pylori in Parkinson's Disease Patients May Be Linked to Greater Severity.

Authors:  Gunasekaran Suwarnalata; Ai Huey Tan; Hidayah Isa; Ranganath Gudimella; Arif Anwar; Mun Fai Loke; Sanjiv Mahadeva; Shen-Yang Lim; Jamuna Vadivelu
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

6.  Anti-Glycan Autoantibodies Induced by Helicobacter pylori as a Potential Risk Factor for Myocardial Infarction.

Authors:  Riccardo Negrini; Vincenzo Villanacci; Claudio Poiesi; Antonella Savio
Journal:  Front Immunol       Date:  2020-04-08       Impact factor: 7.561

Review 7.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.